UHT trades at Wall Street's consensus target of —.
Last 12 months price action with 12-month analyst target path
The base valuation assumes UHT achieves its forward estimates and maintains a stable P/E multiple of 25.6x. This scenario reflects the blended consensus of 1 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 8, 2026, Universal Health Realty Income Trust (UHT) has a Wall Street consensus price target of N/A, based on estimates from 1 covering analysts. The company has a market capitalization of $615M.
Analyst price targets range from a low of N/A to a high of N/A.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, UHT trades at a trailing P/E of 34.9x and forward P/E of 25.6x. Analysts expect EPS to grow +34.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $53.74, with bear and bull scenarios of $33.86 and $70.81 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HRHealthcare Realty Trust Incorporated | $7.2B | $20.65 | $21.83 | +5.7% | Hold | — | 30 |
CHCTCommunity Healthcare Trust Incorporated | $515M | $18.01 | $18.50 | +2.7% | Hold | 38.3x | 16 |
GMREGlobal Medical REIT Inc. | $94M | $35.74 | $40.00 | +11.9% | Buy | 595.7x | 22 |
NTSTNETSTREIT Corp. | $2.2B | $21.96 | $22.69 | +3.3% | Buy | 68.6x | 18 |
PLTKPlaytika Holding Corp. | $1.4B | $3.77 | $3.50 | -7.2% | Hold | 8.8x | 17 |
VTRVentas, Inc. | $44.7B | $94.07 | $95.86 | +1.9% | Buy | 150.8x | 32 |
WELLWelltower Inc. | $166.5B | $237.59 | $237.80 | +0.1% | Buy | 82.0x | 35 |
OHIOmega Healthcare Investors, Inc. | $14.8B | $49.62 | $50.43 | +1.6% | Hold | 25.0x | 28 |
MPWMedical Properties Trust, Inc. | $3.4B | $5.65 | $11.54 | +104.2% | Hold | 49.4x | 28 |
LTCLTC Properties, Inc. | $2.0B | $39.23 | $36.00 | -8.2% | Hold | 20.9x | 22 |
Quick answers to the most common questions about buying UHT stock.
The consensus price target for UHT is $N/A, close to the current price of $44.3 (N/A% implied move). Based on 1 analyst estimates, the stock appears fairly valued near current levels.
UHT has a consensus rating of "Hold" based on 1 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.
UHT trades at a forward P/E of 25.6069x, representing a moderate valuation. With analysts targeting $N/A (N/A% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $N/A for UHT, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $71 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
UHT is lightly followed, with 1 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month UHT stock forecast based on 1 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $54, with bear/bull scenarios of $34/$71.
Our quantitative valuation model calculates UHT's fair value at $54 (base case), with a bear case of $34 and bull case of $71. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
UHT trades at a forward P/E ratio of 25.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 34.9x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
UHT appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
UHT analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $34-$71 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.